Results 141 to 150 of about 10,727,813 (262)

[Stammbuch Beta Khampf] [PDF]

[STAMMBUCH BETA KHAMPF] [Stammbuch Beta Khampf] ( - ) Cover ( - ) Einträge Bl. 1 - 2 ( - ) Titelblatt, Bl. 3 ( - ) Einträge Bl. 4 - 10 ( - ) Einträge Bl. 11 - 20 ( - ) Einträge Bl. 21 - 30 ( - ) Einträge Bl. 31 -
Khampf, Beta
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Bayesian Power-Based Sample Size Determination for Diagnostic Accuracy Studies. [PDF]

Pharm Stat
Shiota S, Horiguchi G, Naito A, Nakata M, Teramukai S.   +4 more
europepmc   +1 more source

Phi Beta Kappa's 43rd Triennial Council

, 2012
43rd Council Committees and Members; Delegates' Manual August 2-4, 2012 Palm Beach ...
Phi Beta Kappa Society
core  

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Endoscopic Band Ligation as an Unmeasured Confounder in the Beta-Blocker-PVT Association. [PDF]

Liver Int
Feng J, Liu L, Gao H.
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Lo spettacolo teatrale

, 2003
La sezione del volume curata da Simone Beta comprende tre capitoli: 1) le feste: le grandi Dionisie, le Lenee, le Dionisie rurali, le Antesterie (pp. 39-48) 2) la struttura e le caratteristiche dei teatri greci; il teatro di Dioniso ad Atene (pp. 49-54)
BETA, SIMONE
core   +1 more source

Preserving Motor Features by Alternative Re-Referencing to Remove Heart Artifact on the Stentrode. [PDF]

Adv Sci (Weinh)
Feldman AK, Kacker K, Yun R, Chetty N, Bennett J, Yoo PE, Nogueira RG, Collinger JL, Opie NL, Oxley TJ, Putrino DF, Weber DJ.   +11 more
europepmc   +1 more source

Derivatives of the Incomplete Beta Function [PDF]

The incomplete beta function is defined as where Beta(p, q) is the beta function. Dutka (1981) gave a history of the development and numerical evaluation of this function. In this article, an algorithm for computing first and second derivatives of Ix,p,q
James F. Robinson-Cox, Robert J. Boik
core